Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FWYUC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,979
Award facts
- Contract value 100% obligated
- $21,978.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,978.87 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive capabilities in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent SPE2DX IDC functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Stelara, a specialty immunosuppressive medication, exemplifies the company's role in supporting critical pharmaceutical needs within the federal healthcare procurement framework.
Quick answers
Who was awarded contract SPE2DB25FWYUC?
SPE2DB25FWYUC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FWYUC worth?
The government has obligated $21,979 on SPE2DB25FWYUC.
Is contract SPE2DB25FWYUC an order under another contract?
Yes. SPE2DB25FWYUC is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWYUC competed?
The extent of competition for SPE2DB25FWYUC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award